Gregg Timony, MS

Vice President of DMPK-Toxicology

Gregg Timony joined Escient in August 2018 as the Senior Director of DMPK-Toxicology. Gregg is an accomplished drug development scientist and leader with 25 years of pharmaceutical/biotechnology industry experience focused on pharmacokinetics (PK) and toxicology in early discovery, R&D, and regulatory settings. While at Genetics Institute, Conforma Therapeutics, and Receptos, he was responsible for design and oversight of the PK and toxicology aspects of IND enabling programs and was the primary/co-author of non-clinical PK, pharmacology or toxicology sections of module 2 for 9 INDs. He has been a frequent contributor to post-IND regulatory documentation including CIB, DSUR, and briefing books, and while at Genetics Institute participated in the early development of three drugs that advanced to market – Neumega®, Infuse®, Benefix®. Gregg holds an MS in pharmacology from Northeastern University.